PAK activity and the PAK-related signaling pathway was downregulated by a small-molecule drug that was designed for gastric cancer cells, and among these were: curcumin [124] for PAK1 and GL-1196 [125], and LC-0882 [126], and LCH-7749944 [127] for PAK4. This evidence concerns the gene PAK1 and gastric cancer.